GlassScriptPhysician profile
Nereida Correa
NPI 1154433209
$2,733.97
in general payments reported to CMS, 2019-2025
23 companies · $600 in 2025
The $600 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $370 · 2021: $393 · 2022: $115 · 2023: $325 · 2024: $110 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.12 |
| Education | $368.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $564.94 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $394.99 | 2019-2025 | Orilissa |
| Merck Sharp & Dohme LLC | $311.47 | 2019-2020 | |
| Shield Therapeutics INC | $268.44 | 2023-2025 | Accrufer |
| Daiichi Sankyo INC. | $181.39 | 2020-2022 | |
| Myovant Sciences INC. | $162.52 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $130.50 | 2021-2025 | |
| Gilead Sciences, INC. | $119.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $105.88 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $96.66 | 2019 | |
| Sage Therapeutics, LLC | $96.65 | 2020 | |
| Therapeuticsmd, INC. | $54.74 | 2019-2022 | |
| Coopersurgical, INC. | $49.87 | 2022-2023 | Paragard T 380a |
| Organon LLC | $41.19 | 2021-2023 | Nexplanon |
| Boston Scientific Corporation | $33.65 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.49 | 2023 | |
| Hikma Pharmaceuticals USA | $18.17 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.43 | 2019 | |
| Hologic Sales and Service, LLC | $14.99 | 2025 | Aptima |
| Evofem Biosciences, INC. | $13.37 | 2021 | |
| Horizon Therapeutics Plc | $13.21 | 2019 | |
| Millicent US INC | $12.66 | 2020 | |
| Allergan, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nereida Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.